BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental Biologics License Application (sBLA) for PALYNZIQ® ...

Sandoz and Polpharma Biologics have become the first companies to get FDA approval for a biosimilar of Biogen's blockbuster multiple sclerosis therapy Tysabri, after overcoming a bid by Biogen to ...

Low-dose zoledronic acid appeared safe among older patients with hip fracture and advanced chronic kidney disease.

GRAIL's topline results from the NHS-Galleri trial were a clear disappointment with no major implications on commercialization. Read why GRAL stock is a hold.

The global pharmacy automation market is projected to grow at a CAGR of approximately 9–10% through 2029. This growth is driven by increasing awareness of pharmacy automation, rapid decentralization ...

Solvej Balle, trans. from the Danish by Jennifer Russell and Sophia Hersi Smith. New Directions, $15.95 trade paper (176p) ISBN 978-0-8112-3841-0 Balle picks up her remarkable seven-part saga of a ...

The prescribed dosage for Privigen (human immunoglobulin g) may vary depending on a person’s individual treatment plan. Other factors, including your specific diagnosis, body weight, and medical ...

Methotrexate should be taken weekly, not daily, to prevent severe toxic effects. Regular tests are needed to monitor blood cell counts, liver enzymes, and kidney function while on methotrexate. Taken ...

BACKGROUND: Intravenous (IV) use of proton pump inhibitors (PPIs) is advised only in cases of suspected upper gastrointestinal bleeding (UGIB) or impossibility of receiving oral medication, although ...

Leqembi Iqlik's subcutaneous injection for Alzheimer's disease received FDA approval, based on Phase III trial data showing comparable efficacy to IV dosing. The subcutaneous formulation demonstrated ...

Bulk drug calculations for different types of active moieties and drugs require different calculations and labeling. Performing calculations for the formulation of pharmaceutical dosage forms and ...

Abstract: Convenient and independent siphons are in basic interest for ease point-of-care testing (POCT) applications in microfluidic fields. In microfluidic research facilities, business siphons (e.g ...